Lilly donating $12.4 million to United Way
Eli Lilly and Co. said Monday it plans to give $12.4 million to the United Way, the largest single charitable donation in the company’s history.
Health Care
Articles
Lawmakers brace for health law, potential costs
Indiana lawmakers can add confusion over the federal health insurance law to their already overflowing plate when they return for their 2013 legislative session in January.
Pence solidifies opposition to state exchange
Indiana Gov.-elect Mike Pence closed the door on a state-run health insurance exchange Thursday, arguing that the estimated $50 million cost of the state program was not worth the limited autonomy granted in return.
Drugmakers collaborate to facilitate drug tests
Eli Lilly and Co. and two other major drugmakers say they are collaborating in a global project aimed at getting patient tests of experimental drugs up and running more quickly and efficiently.
Indy loses promising health startup
LabDoor, which soon will launch an iPhone app that assigns A-F grades to over-the-counter vitamins and medicines, moved last month from Indianapolis to San Francisco, where it received $100,000 in startup financing.
Health officials: Indiana needs more trauma centers
Health officials developing a statewide trauma system say Indiana needs more trauma centers.
Indiana’s top state budget official finds new job
The top state budget official under Indiana Gov. Mitch Daniels has decided to move into an executive position with Indiana University Health when the governor's term ends in January.
WellPoint shares droop despite profitable quarter
WellPoint Inc.'s third-quarter earnings trumped Wall Street expectations, but the health insurer's stock tumbled Wednesday after President Barack Obama won re-election, a victory that could help cement the future of his health care overhaul.
Low enrollment clouds Healthy Indiana Plan
Many Indiana Republicans want to use the Healthy Indiana Plan to expand Medicaid coverage in Indiana to more low-income adults. But the program—which offers health insurance based on health savings accounts to uninsured adults—has managed to attract just one-third of the Hoosiers it was designed for and has cost about twice as much per enrollee as predicted.
Lilly to spend $140M on new insulin cartridge plant
About 100 workers will staff the new plant, which will be constructed by spring 2014 and ready for operations in 2015. But only “some” of that number will be new hires.
Lilly plans expansion of local insulin plant
The Indianapolis-based drugmaker plans to expand its local insulin plants to make insulin cartridges to meet what it describes as growing demand in the United States.
Lilly’s Cialis receives European approval for new use
The European Union has approved Eli Lilly and Co.'s erectile dysfunction drug Cialis to treat symptoms tied to an enlarged prostate.
Colts QB Luck, Riley Hospital reach multiyear promotional deal
Indianapolis Colts rookie quarterback Andrew Luck on Tuesday will announce his first local sponsorship deal, a four-year pact with Riley Hospital for Children at Indiana University Health.
Zimmer trims full-year forecast after quarterly profit falls
The Warsaw-based maker of orthopedic implants beat analysts’ estimates with its third-quarter earnings, but lowered its full-year forecast.
Amerigroup shareholders approve $4.9B sale to WellPoint
Shareholders of Amerigroup Corp. overwhelming approved the Virginia company’s sale for $4.9 billion to Indianapolis-based health insurer WellPoint Inc. in a vote on Tuesday. The vote clears the way for the acquisition to close before the end of the year.
Lilly CEO calls for life sciences research institute
Eli Lilly CEO John Lechleiter on Tuesday called for creation of a “world-class” research institute in Indianapolis to bring together scientists from universities and corporations to develop new medical therapies and companies.
Lilly says experimental diabetes drug outperformed rivals
Eli Lilly and Co. said dulaglutide lowered blood sugar better than three existing diabetes drugs in three Phase 3 clinical trials. Analysts expect the drug to hit the market in 2014 or 2015 and become a blockbuster.
Alzheimer’s prevention seen promising as drug cures fail
Researchers are set to test drugs by Eli Lilly and other companies that may prevent Alzheimer’s disease after efforts to find a cure have been unsuccessful.
WellPoint reorganizes into four business units
Separate Medicare and Medicaid divisions each will sell plans for those government-backed insurance programs. Another will handle commercial and individual business, and a specialty unit will provide dental, vision and disability coverage.
Lilly, Roche drugs chosen for Alzheimer’s prevention trial
Eli Lilly & Co.’s solanezumab and Roche Holding AG’s gantenerumab were selected for a long-term Alzheimer’s trial run by Washington University at St. Louis scientists seeking to block the disease’s symptoms.